GSE176008 pyridoxine 7 v 1 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE176008_pyridoxine_7_v_1_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE176008_pyridoxine_7_v_1_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE176008_pyridoxine_7_v_1_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE176008_pyridoxine_7_v_1_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

long intergenic non-protein coding RNA 632

Gene

long intergenic non-protein coding RNA 940

Gene

DEAD-box helicase 55 pseudogene 1

Gene

uncharacterized LOC100505782

Gene

RNA, 7SL, cytoplasmic 811, pseudogene

Gene

BTB domain containing 10 pseudogene 1

Gene

C10orf67 antisense RNA 1

Gene

keratin 18 pseudogene 15

Gene

ribosomal protein L7a pseudogene 53

Gene

GCNA pseudogene 1

  • Gene

    long intergenic non-protein coding RNA 632


  • Gene

    long intergenic non-protein coding RNA 940


  • Gene

    DEAD-box helicase 55 pseudogene 1


  • Gene

    uncharacterized LOC100505782


  • Gene

    RNA, 7SL, cytoplasmic 811, pseudogene


  • Gene

    BTB domain containing 10 pseudogene 1


  • Gene

    C10orf67 antisense RNA 1


  • Gene

    keratin 18 pseudogene 15


  • Gene

    ribosomal protein L7a pseudogene 53


  • Gene

    GCNA pseudogene 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.